BAFNA PHARMACEUTICALS
Back to All Ratios
|
BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 14.53 | 13.96 | 11.09 | 22.79 | 30.42 |
What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 14.53 |
| Mar2024 | 13.96 |
| Mar2023 | 11.09 |
| Mar2022 | 22.79 |
| Mar2021 | 30.42 |
How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 14.53 | 4.08 | |
| Mar2024 | 13.96 | 25.88 | |
| Mar2023 | 11.09 | -51.34 | |
| Mar2022 | 22.79 | -25.08 | |
| Mar2021 | 30.42 | - | |
Other Financial Ratios of BAFNA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹634.7 Cr | 7.6% | 19% | 221.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 7.6% |
19% |
221.8% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses